Oral Dalfampridine Improves Standing Balance Detected at Static Posturography in Multiple Sclerosis

We report a 14-week post-marketing experience on 20 patients with multiple sclerosis (MS) who started prolonged-release (PR) oral dalfampridine 10 mg twice daily according to European Medicine Agency criteria. They underwent serial static posturography assessments and the dizziness handicap inventor...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Prosperini, Luca, Giannì, Costanza, Fortuna, Deborah, Marchetti, Maria Rita, Pozzilli, Carlo
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2014
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3985326/
https://ncbi.nlm.nih.gov/pubmed/24800078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/802307
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky